Google’s two-qubit strategy: What the neutral atom expansion means for IonQ, QuEra, and the future of quantum computing
Can Oracle (NYSE: ORCL) turn enterprise AI from demo theater into operational software that actually runs the business?
Read More 5 minute read Pharma Industry News Is a C$16m LIFE offering from ZYUS Life Sciences the catalyst investors are watching in cannabinoid pharma? ZYUS Life Sciences launches a C$15–16 million LIFE offering to accelerate clinical execution and regulatory readiness. Find out what it means for investors. bySoujanya RaviJanuary 15, 2026